PODD · News · 20260805N

Omnipod Quality Corrections

INSULET CORP · 2026-08-05 · Importance 59 · Surprise 60

Insulet’s Omnipod platform was affected by two voluntary medical-device corrections tied to manufacturing and quality-control issues. Third-party reports said approximately 7 million Pods were subject to corrections, creating risks of insulin under-delivery. The developments have raised concerns about product reliability, manufacturing controls, and potential reputation damage among users and investors.

Key facts

• Levi & Korsinsky reported a 16-month pattern of manufacturing quality and product safety representations preceded two Omnipod Medical Device Corrections and approximately $24 per share in combined immediate stock declines. source